Recall Atlas
Drugs & medicalClass II

Radnostix recalls Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333,…

Presence of Particulate Matter: Due to production issues

Read the official notice →
Date
2026-03-11
Country
United States
Brand
Radnostix
Product
Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333,…
Classification
Class II
Units
Nationwide in the USA and Puerto Rico
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Radnostix recalls

  1. 2026-04-01
  2. US
    Drugs & medicalClass III

    Radnostix recalls Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg,…

    Failed Tablet/Capsule Specifications

    FDA · DrugRadnostixNationwide in the US, including Puerto RicoOfficial notice →
All 2 Radnostix recalls →

Other drugs & medical recalls in the United States

  1. 2026-03-11
  2. US
    Drugs & medicalClass I

    StuffbyNainax recalls MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7

    Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

    FDA · DrugStuffbyNainaxProduct was distributed to 4 customers in the US.Official notice →
  3. US
    Drugs & medicalClass I

    Mohamed Hagar recalls Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0

    Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).

    FDA · DrugMohamed HagarU.S. NationwideOfficial notice →
  4. US
    Drugs & medicalClass II

    New Life Pharma LLC recalls Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06

    Lack of Assurance of Sterility

    FDA · DrugNew Life Pharma LLCOHOfficial notice →
  5. US
    Drugs & medicalClass I

    ANTHONY TRINH, 123Herbals LLC recalls SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

    Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

    FDA · DrugANTHONY TRINH, 123Herbals LLCUSA nationwideOfficial notice →
  6. US
    Drugs & medicalClass II

    HTO Nevada Inc. dba Kirkman recalls FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR…

    Stability Data Does Not Support Expiry Date.

    FDA · DrugHTO Nevada Inc. dba KirkmanNationwide within the U.SOfficial notice →
  7. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc.,…

    Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

    FDA · DrugRising Pharma Holding, Inc.Nationwide within the U.SOfficial notice →
See all drugs & medical recalls →